vertex pharmaceuticals

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were picking shares last week in the wake of earnings beats. One oil exploration and production CEO returned to the buy window during the week too. Conventional...

This weekend's Barron's provides some insight into Cathie Wood, one of Barron's 100 most influential women in the United States this year. Other featured articles discuss how Barron's ugly stock picks have fared since last summer, two companies that are reinventing themselves and...

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insiders at some consumer products companies were adding to their stakes this past week. A few biotech companies saw insiders acquiring some shares as well. Conventional wisdom says that insiders...

This weekend's Barron's cover story offers ways to profit from the digital-payment future. Other featured articles discuss how to invest in the post-COVID world, where to look overseas for bargains, and how Bill Ackman is positioned now. Also, the prospects for a supermarket operator, a...

Benzinga has featured a look at many investor favorite stocks over the past week. Some recent posts took a look back at the past year. Many others were forward focused, including forecasts for the top tech darling. The end of the year is nearly upon us. As it does every week, Benzinga...

Benzinga has featured a look at many investor favorite stocks over the past week. Bullish calls featured a global footwear maker and a streaming video giant. Bearish calls included a semiconductor giant and the leading electric vehicle maker. Autumn has begun, often a shaky time for the markets...

This weekend's cover story in Barron's takes a look at potential winners as the biotech industry grapples with soaring drug prices. Other featured articles offer the prospects for an apparel maker poised to rebound and a railroad-equipment supplier with global opportunities. The outlook for a...

Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) has received a price target increase to $24 from $17 from Cantor Fitzgerald, which reiterated an Overweight rating following positive data from the company’s Phase 2 study in Cystic Fibrosis. “Treatment with anabasum at the highest dose...

Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...

Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the few that bucked the trend in those two weeks. Shares of both of these stocks rose sharply during the two-week period. Short sellers shied away from many of the...

Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out as leaders of that trend in those two weeks. Shares of one of those two stocks rose while the other slumped during the period. Short sellers moved on only a few of the leading...

Short interest in many leading biotech stocks declined in the most recent period. Bucking that trend is a biotech company that soon will be acquired by an overseas peer. Short sellers retreated most sharply from a biotech that some analysts now see as a value stock. Between the March 31 and April...

The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...

Short interest moves in leading biotech stocks were mixed in the most recent period. However, Illumina, Inc. (NASDAQ: ILMN) and Baxalta Inc (NYSE: BXLT) saw sharp increases in their short interest in late November. Short sellers appeared to lose interest in Juno Lighting LLC (NASDAQ: JUNO) late in...

Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...